DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Retrovir (Zidovudine) - Adverse Event Reports - Life Threatening Events

 



Index of reports > Cases resulting in life threatening events (13)

     Drug Exposure During Pregnancy (4)Alanine Aminotransferase Increased (3)Pregnancy (3)Anaemia (2)Convulsion (2)Gamma-Glutamyltransferase Increased (2)Aspartate Aminotransferase Increased (2)Neutropenia (2)Heart Disease Congenital (2)Blood Creatinine Increased (2)

Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in life threatening events.

Adverse event in 36 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-10-01

Patient: 36 year old male

Adverse reactions / side effects: Blood Urea Increased, AIDS Encephalopathy, Altered State of Consciousness, Blood Creatinine Increased, Renal Failure Chronic, Convulsion, Nephropathy

Adverse event resulted in: life threatening event

Suspect drug(s):
Baktar
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    Start date: 2006-04-01

Darunavir
    Indication: Drug USE FOR Unknown Indication

Epivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-09-19
    End date: 2007-03-17

Norvir
    Dosage: 100mg as directed
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-04-07
    End date: 2007-03-17

Norvir
    Dosage: 200mg unknown
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2003-05-20
    End date: 2003-11-10

Retrovir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2000-09-19
    End date: 2006-12-11

Tipranavir
    Indication: Drug USE FOR Unknown Indication

Viread
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2003-05-20
    End date: 2006-11-14

Ziagen
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2002-11-26
    End date: 2007-03-17

Zithromax
    Administration route: Oral
    Indication: Opportunistic Infection Prophylaxis
    Start date: 2002-04-09

Other drugs received by patient: Unknown Drug; Unknown Drug



Adverse event in 45 year old male receiving Retrovir (Zidovudine)

Reported by a physician from Japan on 2007-07-31

Patient: 45 year old male, weighing 56.0 kg (123.2 pounds)

Adverse reactions / side effects: Pneumonia, Acute Respiratory Distress Syndrome, Pancytopenia, Histoplasmosis Disseminated, Pyrexia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Crixivan
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-04

Daraprim
    Administration route: Oral
    Indication: Cerebral Toxoplasmosis
    Start date: 2001-08-25
    End date: 2001-08-31

Daraprim
    Administration route: Oral
    Start date: 2001-09-01
    End date: 2001-09-06

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2001-08-27
    End date: 2001-09-04

Other drugs received by patient: Epivir; Clindamycin Hydrochloride; Dalacin S; Hydrocortone; Prednisolone; Prednisolone; Prednisolone; Prednisolone; Glyceol; Glyceol; Glyceol



Adverse event in 2 month old male receiving Retrovir (Zidovudine)

Reported by a physician from France on 2007-07-16

Patient: 2 month old male

Adverse reactions / side effects: Gastrointestinal Malformation, Heart Disease Congenital, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Start date: 2001-03-27
    End date: 2001-08-11

Retrovir
    Start date: 2001-03-27
    End date: 2001-08-11

Videx
    Start date: 2001-06-12
    End date: 2001-08-11



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-13

Patient: male

Adverse reactions / side effects: Heart Disease Congenital, Duodenal Atresia

Adverse event resulted in: life threatening event

Suspect drug(s):
Epivir
    Start date: 2001-03-27
    End date: 2001-11-08

Retrovir
    Start date: 2001-03-27
    End date: 2001-11-08

Videx
    Start date: 2001-06-12
    End date: 2001-11-08



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-29

Patient: male, weighing 2.8 kg (6.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Combivir
    Indication: Antiviral Prophylaxis
    Start date: 2005-02-17
    End date: 2005-04-06

Retrovir
    Dosage: 1.1ml twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2005-04-06
    End date: 2005-05-17

Other drugs received by patient: Retrovir; Kaletra



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-06-18

Patient: male, weighing 3.4 kg (7.5 pounds)

Adverse reactions / side effects: Anaemia, Pallor, Blood Lactic Acid Increased

Adverse event resulted in: life threatening event

Suspect drug(s):
Retrovir (Zidovudine)



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Invirase
    Dosage: exposure during gestation.

Norvir
    Dosage: exposure during gestation.

Retrovir
    Dosage: exposure during delivery.
    Start date: 1999-07-02
    End date: 1999-07-02

Retrovir
    Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
    Indication: Prophylaxis
    Start date: 1999-07-02
    End date: 1999-08-10

Retrovir
    Administration route: Oral
    Start date: 1999-07-07
    End date: 1999-07-18

Videx
    Dosage: exposure during gestation.

Zerit
    Dosage: exposure during gestation.

Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol



Adverse event in 4 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from Denmark on 2007-03-30

Patient: 4 year old male, weighing 17.0 kg (37.4 pounds)

Adverse reactions / side effects: Haemoglobin Decreased, Bone Marrow Failure, Neutropenia, Thrombocytopenia, Reticulocytopenia, Pneumococcal Sepsis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Retrovir (Zidovudine)

Other drugs received by patient: Epivir; Viramune; Bactrim



Adverse event in 59 year old male receiving Retrovir (Zidovudine)

Reported by a pharmacist from United States on 2007-03-30

Patient: 59 year old male

Adverse reactions / side effects: Incorrect Dose Administered, Bone Marrow Failure

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Retrovir
    Dosage: 300 mg every 12 hours oral
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2006-11-21
    End date: 2007-01-31

Retrovir
    Dosage: 300 mg every 12 hours oral
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-11-21
    End date: 2007-01-31



Adverse event in female receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-03-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Necrotising Enterocolitis Neonatal

Adverse event resulted in: life threatening event

Suspect drug(s):
Retrovir
    Dosage: 1.6mg twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-01-19
    End date: 2007-01-26

Retrovir
    Dosage: 2mg twice per day
    Administration route: Oral
    Start date: 2007-01-26
    End date: 2007-02-08

Other drugs received by patient: Antiretroviral Medications



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12

Patient: male

Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Dosage: transplacentary
    Indication: HIV Infection

Nevirapine
    Dosage: transplacentary
    Indication: HIV Infection

Retrovir
    Dosage: oral
    Administration route: Oral

Retrovir
    Dosage: transplacentary
    Indication: HIV Infection

Stavudine
    Dosage: transplacentary
    Indication: HIV Infection



Adverse event in 1 year old male receiving Retrovir (Zidovudine)

Reported by a consumer/non-health professional from France on 2007-01-19

Patient: 1 year old male

Adverse reactions / side effects: Malaise, Drug Exposure During Pregnancy, Pregnancy

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Bactrim

Combivir

Kaletra

Retrovir



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a individual with unspecified qualification from Japan on 2007-01-12

Patient: male

Adverse reactions / side effects: Agranulocytosis, Hepatic Function Abnormal, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 2005-10-11

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 1999-02-18

Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 2005-10-04

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1996-06-22
    End date: 2004-08-19

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009